{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T08:07:53Z","timestamp":1784102873744,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["GAP 2145"],"award-info":[{"award-number":["GAP 2145"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["CSIR-IIIM\/IPR\/00620"],"award-info":[{"award-number":["CSIR-IIIM\/IPR\/00620"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.cyto.2023.156398","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T10:13:09Z","timestamp":1696846389000},"page":"156398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Anti-inflammatory and anti-arthritic potential of methotrexate in combination with BA-25, an amino analogue of \u03b2-boswellic acid in the treatment of rheumatoid arthritis"],"prefix":"10.1016","volume":"172","author":[{"given":"Rupali","family":"Choudhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diksha","family":"Saroch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diljeet","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobia","family":"Anjum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nusrit Iqbal","family":"Andrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tazeem","family":"Akram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhahwal Ali","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanket K.","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha","family":"Bhagat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4886-9234","authenticated-orcid":false,"given":"Gurleen","family":"Kour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zabeer","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2023.156398_b0005","doi-asserted-by":"crossref","unstructured":"Q. Guo et al. Rheumatoid Arthritis: Pathological Mechanisms and Modern Pharmacologic Therapies 6 1 2018 15.","DOI":"10.1038\/s41413-018-0016-9"},{"key":"10.1016\/j.cyto.2023.156398_b0010","doi-asserted-by":"crossref","unstructured":"V. Malmstr\u00f6m A.I. Catrina L.J.N.R.I. Klareskog The Immunopathogenesis of Seropositive Rheumatoid Arthritis: from Triggering to Targeting 17 1 2017 60 75.","DOI":"10.1038\/nri.2016.124"},{"key":"10.1016\/j.cyto.2023.156398_b0015","doi-asserted-by":"crossref","unstructured":"F.A. Figus et al. Rheumatoid Arthritis: Extra-Articular Manifestations and Comorbidities 20 4 2021 102776.","DOI":"10.1016\/j.autrev.2021.102776"},{"key":"10.1016\/j.cyto.2023.156398_b0020","doi-asserted-by":"crossref","unstructured":"S. Mateen et al. Understanding the Role of Cytokines in the Pathogenesis of Rheumatoid Arthritis 455 2016 161 171.","DOI":"10.1016\/j.cca.2016.02.010"},{"key":"10.1016\/j.cyto.2023.156398_b0025","doi-asserted-by":"crossref","unstructured":"G.R. Burmester J.E Pope, Novel Treatment Strategies in Rheumatoid Arthritis 389 10086 2017 2338 2348.","DOI":"10.1016\/S0140-6736(17)31491-5"},{"key":"10.1016\/j.cyto.2023.156398_b0030","first-page":"502","article-title":"Side effects of methotrexate therapy for rheumatoid arthritis","volume":"158","author":"Wang","year":"2018","journal-title":"A systematic review."},{"key":"10.1016\/j.cyto.2023.156398_b0035","doi-asserted-by":"crossref","unstructured":"V.C. Rom\u00e3o et al. Three Decades of Low-Dose Methotrexate in Rheumatoid Arthritis: Can We Predict Toxicity? 60 2014 289 310.","DOI":"10.1007\/s12026-014-8564-6"},{"key":"10.1016\/j.cyto.2023.156398_b0040","doi-asserted-by":"crossref","unstructured":"P.-L. Meroni G.J.B. Valesini Tumour Necrosis Factor \u03b1 Antagonists in the Treatment of Rheumatoid Arthritis: An Immunological Perspective. 28 2014 5 13.","DOI":"10.1007\/s40259-013-0063-0"},{"key":"10.1016\/j.cyto.2023.156398_b0045","series-title":"Seminars in Cancer Biology","article-title":"Anti-inflammatory and anti-cancer activities of frankincense: Targets, treatments and toxicities","author":"Efferth","year":"2022"},{"key":"10.1016\/j.cyto.2023.156398_b0050","doi-asserted-by":"crossref","unstructured":"S. Sharma et al. Analogues of Boswellic Acids as Inhibitors of pro-Inflammatory Cytokines TNF-\u03b1 and IL-6 26 2 2016 695 698.","DOI":"10.1016\/j.bmcl.2015.11.035"},{"key":"10.1016\/j.cyto.2023.156398_b0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cyto.2017.12.004","article-title":"The amino analogue of \u03b2-boswellic acid efficiently attenuates the release of pro-inflammatory mediators than its parent compound through the suppression of NF-\u03baB\/I\u03baB\u03b1 signalling axis","volume":"107","author":"Gupta","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2023.156398_b0060","doi-asserted-by":"crossref","first-page":"105618","DOI":"10.1016\/j.phrs.2021.105618","article-title":"Phytochemical add-on therapy to DMARDs therapy in rheumatoid arthritis: In vitro and in vivo bases, clinical evidence and future trends","volume":"169","author":"Kour","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.cyto.2023.156398_b0065","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update","volume":"79","author":"Smolen","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2023.156398_b0070","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejmech.2018.09.027","article-title":"Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review","volume":"158","author":"Wang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.cyto.2023.156398_b0075","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.3390\/cells10113017","article-title":"Recent advances in understanding the pathogenesis of rheumatoid arthritis: New treatment strategies","volume":"10","author":"Mueller","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.cyto.2023.156398_b0080","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/med.21599","article-title":"Inducible nitric oxide synthase: Regulation, structure, and inhibition","volume":"40","author":"Cinelli","year":"2020","journal-title":"Med. Res. Rev."},{"issue":"7","key":"10.1016\/j.cyto.2023.156398_b0085","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive oxygen species in inflammation and tissue injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"23","key":"10.1016\/j.cyto.2023.156398_b0090","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.3390\/ijms20236008","article-title":"Cytokines in inflammatory disease","volume":"20","author":"Kany","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.cyto.2023.156398_b0095","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000087104","article-title":"Cytokine dysregulation, inflammation and well-being","volume":"12","author":"Elenkov","year":"2005","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.cyto.2023.156398_b0100","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nprot.2007.173","article-title":"RosloniecEF. Collagen-induced arthritis","volume":"2","author":"BrandDD","year":"2007","journal-title":"Nat. Protoc."},{"issue":"suppl 1","key":"10.1016\/j.cyto.2023.156398_b0105","doi-asserted-by":"crossref","first-page":"i103","DOI":"10.1136\/ard.59.suppl_1.i103","article-title":"Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis","volume":"59","author":"Schiff","year":"2000","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.cyto.2023.156398_b0110","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s40744-020-00219-2","article-title":"Understanding the role of interleukin-6 (IL-6) in the joint and beyond: A comprehensive review of IL-6 inhibition for the management of rheumatoid arthritis","volume":"7","author":"Favalli","year":"2020","journal-title":"Rheumatology and Therapy"},{"issue":"49","key":"10.1016\/j.cyto.2023.156398_b0115","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15557\/JoU.2012.0007","article-title":"The pathogenesis of rheumatoid arthritis in radiological studies. Part I: Formation of inflammatory infiltrates within the synovial membrane","volume":"12","author":"Sudo\u0142-Szopi\u0144ska","year":"2012","journal-title":"J. Ultrasonography"},{"issue":"2","key":"10.1016\/j.cyto.2023.156398_b0120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5114\/reum.2018.75523","article-title":"Cartilage and bone damage in rheumatoid arthritis","volume":"56","author":"Ostrowska","year":"2018","journal-title":"Reumatologia\/rheumatology"},{"issue":"1","key":"10.1016\/j.cyto.2023.156398_b0125","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther"},{"issue":"4","key":"10.1016\/j.cyto.2023.156398_b0130","doi-asserted-by":"crossref","first-page":"L622","DOI":"10.1152\/ajplung.00477.2005","article-title":"NF-\u03baB activation as a pathological mechanism of septic shock and inflammation","volume":"290","author":"Liu","year":"2006","journal-title":"American J. Physiology-Lung Cellular and Molecular Physiology"},{"issue":"6","key":"10.1016\/j.cyto.2023.156398_b0135","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/ard.2008.088112","article-title":"Thymic function in juvenile idiopathic arthritis","volume":"68","author":"Lorenzi","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.cyto.2023.156398_b0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41413-018-0016-9","article-title":"Rheumatoid arthritis: Pathological mechanisms and modern pharmacologic therapies","volume":"6","author":"Guo","year":"2018","journal-title":"Bone Res."},{"issue":"2","key":"10.1016\/j.cyto.2023.156398_b0145","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/BOR.0000000000000251","article-title":"The thymus and rheumatology: Should we care?","volume":"28","author":"Cosway","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156398_b0150","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/13813455.2019.1620785","article-title":"Hepatoprotective effects of silymarin against diclofenac-induced liver toxicity in male rats based on biochemical parameters and histological study","volume":"127","author":"Heidarian","year":"2021","journal-title":"Arch. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.cyto.2023.156398_b0155","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/cdd.2017.186","article-title":"BCL-2 family proteins: Changing partners in the dance towards death","volume":"25","author":"Kale","year":"2018","journal-title":"Cell Death Differ."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623002764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623002764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T10:08:39Z","timestamp":1736417319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466623002764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":31,"alternative-id":["S1043466623002764"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156398","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-inflammatory and anti-arthritic potential of methotrexate in combination with BA-25, an amino analogue of \u03b2-boswellic acid in the treatment of rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156398","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"156398"}}